生物
NAD+激酶
炎症
细胞生物学
生物化学
免疫学
酶
作者
Balamurugan Sundaram,Pandian Nagakannan,Hee Jin Kim,Hadia M. Abdelaal,Raghvendra Mall,Omkar Indari,Roman Sarkar,Rebecca E. Tweedell,Emily Alonzo,Jonathon Klein,Shondra M. Pruett‐Miller,Peter Vogel,Thirumala‐Devi Kanneganti
出处
期刊:Cell
[Cell Press]
日期:2024-06-14
卷期号:187 (15): 4061-4077.e17
被引量:27
标识
DOI:10.1016/j.cell.2024.05.034
摘要
NLRs constitute a large, highly conserved family of cytosolic pattern recognition receptors that are central to health and disease, making them key therapeutic targets. NLRC5 is an enigmatic NLR with mutations associated with inflammatory and infectious diseases, but little is known about its function as an innate immune sensor and cell death regulator. Therefore, we screened for NLRC5's role in response to infections, PAMPs, DAMPs, and cytokines. We identified that NLRC5 acts as an innate immune sensor to drive inflammatory cell death, PANoptosis, in response to specific ligands, including PAMP/heme and heme/cytokine combinations. NLRC5 interacted with NLRP12 and PANoptosome components to form a cell death complex, suggesting an NLR network forms similar to those in plants. Mechanistically, TLR signaling and NAD+ levels regulated NLRC5 expression and ROS production to control cell death. Furthermore, NLRC5-deficient mice were protected in hemolytic and inflammatory models, suggesting that NLRC5 could be a potential therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI